171 programming-"https:"-"FEMTO-ST"-"UCL" "https:" "https:" "https:" "https:" "https:" "Dr" "P" uni jobs at Cardiff University
Sort by
Refine Your Search
-
industrial experience within the following research fields: Main group (p-block) chemistry; Coordination chemistry and organic synthesis; Sustainable synthesis and
-
team player and be able to adapt to a broad range of duties and challenges. Informal enquiries about the post may be directed to Dr R Jenkins, Deputy School Manager (JenkinsR1@cardiff.ac.uk; 029 2087
-
, to deliver a knee joint analysis pipeline capable of driving surgical innovation beyond 2030. The work program, based at Cardiff University, and in collaboration with Katholik University Leuven, Belgium and
-
. For informal enquiries about the post, please contact Dr Emmanouil Perisoglou (Principal Investigator) at PerisoglouE@cardiff.ac.uk or Dr Juan Fernandez Goycoolea (Co-Investigator) at FernandezGoycooleaJP
-
UK and SMF. For informal enquiries candidates should contact Dr James Pearson (Pearsonj1@cardiff.ac.uk). This post is part time (14 hours per week), available immediately for 8 months. Flexible working
-
James Field, Director of Learning and Teaching (FieldJ2@cardiff.ac.uk) or Dr James Hyde, Programme Lead for Dental Hygiene and Dental Therapy (HydeJ2@cardiff.ac.uk) for an informal, confidential
-
of the UKRI-funded Future Leader Fellowship project investigating epigenetic regulation of lung fibrosis led by Dr Renata Jurkowska at the School of Biosciences, Cardiff University. You will work
-
to work in the Viral ImmunoTherapies and Advanced therapeutics Laboratory (VITAL), in the research team of Dr Emily Bates. This funding is awarded by UKRI Proof of Concept Grant and will evaluate precision
-
, of the university transformation and change portfolios of programmes and projects. The role will support the development and maintenance of portfolio, programme and project activities aligned to the Project
-
the Viral ImmunoTherapies and Advanced therapeutics Laboratory (VITAL), in the research team of Dr Carly Bliss. This funding is awarded by Advancing Radiotherapy Cymru (ARC) and Cancer Research UK, and